6191 - 6200 of 7877 Results
Title
Year
-
RESTRICTEDTitle: Adaptive preconditioning in neurological diseases – therapeutic insights from proteostatic perturbationsJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1648Issue #:Start Page: 603End Page: 616Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.brainres.2016.02.033Best OA location URL: https://doi.org/10.1016/j.brainres.2016.02.033Citation Count: 39
-
OPENTitle: Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrumJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 46Issue #:Start Page: 32End Page: 42Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.06.003Best OA location URL: https://europepmc.org/articles/pmc5018437?pdf=renderCitation Count: 22
-
RESTRICTEDTitle: Gene therapy to target ER stress in brain diseasesJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1648Issue #:Start Page: 561End Page: 570Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2016.04.064Citation Count: 31
-
RESTRICTEDTitle: Injury to the nervous system: A look into the ERJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1648Issue #:Start Page: 617End Page: 625Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2016.04.053Citation Count: 24
-
RESTRICTEDTitle: LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectivesJournal Name: Clinical Pharmacology: Advances and ApplicationsPublisher: Informa UK LimitedVol: Volume 8Issue #:Start Page: 177End Page: 189Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/cpaa.s102191Best OA location URL: https://www.dovepress.com/getfile.php?fileID=33080Citation Count: 41
-
OPENTitle: Perspective: Data sharing for discoveryJournal Name: NaturePublisher: Springer Science and Business Media LLCVol: 538Issue #: 7626Start Page: S4End Page: S4Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/538s4aBest OA location URL: https://www.nature.com/articles/538S4a.pdfCitation Count: 6
-
OPENTitle: Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's diseaseJournal Name: Progress in Neuro-Psychopharmacology and Biological PsychiatryPublisher: Elsevier BVVol: 70Issue #:Start Page: 77End Page: 84Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.pnpbp.2016.05.004Best OA location URL: https://europepmc.org/articles/pmc5410378?pdf=renderCitation Count: 24
-
RESTRICTEDTitle: The best medicine? The influence of physical activity and inactivity on Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 10Start Page: 1444End Page: 1454Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26728Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491025Citation Count: 97
-
RESTRICTEDTitle: Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 113Issue #:Start Page: 110End Page: 123Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.09.028Citation Count: 54
-
OPENTitle: Cognitive impairment in Parkinson's disease: Association between patient-reported and clinically measured outcomesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 33Issue #:Start Page: 107End Page: 114Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.09.025Best OA location URL: https://europepmc.org/articles/pmc5154808?pdf=renderCitation Count: 24